Basics of Compounding for Raynaud's Disease

Author(s):  Glasnapp Andrew

Issue:  Jul/Aug 2003 - After the Women's Health Initiative Trial
View All Articles in Issue

Abstract:  This discussion of Raynaud’s disease focuses on etiology, pathophysiology, clinical manifestations, diagnosis, prognosis, treatment and recommendations. Tables provide information about drugs of choice for treating Raynaud’s disease and/or Raynaud’s phenomenon, nutritional supplements that may safely reduce the severity and frequency of attacks and sample formulations for treating Raynaud’s disease (Nifedipine in PLO Gel, Nitroglycerin 0.2% Ointment, Coenzyme Q10 100 mg-in-Oil Capsules and Zinc, Magnesium, Calcium and Vitamin D3 Oral Liquid).

Related Keywords: Calcium, for the treatment of Raynaud's disease , Coenzyme Q10, for the treatment of Raynaud's disease , Coenzyme Q10 in oil capsules, for the treatment of Raynaud's disease , Lecithin, for the treatment of Raynaud's disease , Magnesium, for the treatment of Raynaud's disease , Nifedipine in Pluronic lecithin organogel, for the treatment of Raynaud's disease, Nitroglycerin 0.2% ointment, for the treatment of Raynaud's disease, Nutritional supplements, for treatment of Raynaud's disease, Raynaud's disease, compounding for, Raynaud's phenomenon, treatment of, Vitamin E, for the treatment of Raynaud's disease , Zinc, for the treatment of Raynaud's disease , Zinc, magnesium, calcium, and vitamin D3 oral liquid, for the treatment of Raynaud's disease

Related Categories: DERMATOLOGY, PAIN MANAGEMENT

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=1519

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products